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S.C. Gibson,1* A. Marsh,1 C. Berry,2 C. Payne,1 D.S. Byrne,1 P.N. Rogers,1
A.J. McKay,1 H. Dargie2 and D.B. Kingsmore1Departments of 1General and Vascular Surgery, Gartnavel General Hospital, and 2Cardiology, Western
Infirmary Hospital, Glasgow, UKObjectives. The objective of this study was to ascertain the benefit of routine pre-operative cardiac troponin I (cTnI)
measurement in patients undergoing major lower extremity amputation for critical limb ischaemia.
Design. This was a prospective, blinded observational study.
Methods. All patients scheduled for lower extremity amputation, without evidence of unstable coronary artery disease were
recruited prospectively over a period of 1 year. In addition to routine pre-operative evaluation, a blood sample was taken for
measurement of serum cTnI. Post-operative screening was conducted for cardiac events with patients followed up to 6 weeks.
Results. Ten of the 44 patients included suffered a non-fatal myocardial infarction or died from a cardiac cause post-
operatively. A rise in pre-operative cTnI was associated with a very poor outcome (two cardiac deaths and one post-operative
myocardial infarction) and was the only significant predictor of post-operative cardiac events.
Conclusion. Routine pre-operative cTnI measurement may be of use to identify patients at high risk of cardiac complication
who would benefit from optimization of cardiac status or in whom surgery could be deferred.Keywords: Lower extremity amputation; Cardiac troponin I; Cardiac complications; Pre-operative risk stratification.Introduction
Patients requiring lower extremity amputation have a
high associated peri-operative risk, with reported 30-
day mortality rates of up to 17%.1 The commonest
cause of death after surgery is myocardial infarction
(MI),2 confirmed by pathological studies that report up
to 92% of patients with peripheral arterial disease
significant enough to warrant amputation have diffuse
and severe coronary artery atherosclerosis.3
Cardiac troponin I (cTnI) is a contractile protein that
is released into the circulation after myocardial cell
injury. It is not found in skeletal muscle and is,
therefore, a sensitive and specific marker of myocar-
dial necrosis and cardiac events.4,5 Whilst a raised
post-operative level of cTnI has been found to correlate
with all cause mortality in medium term follow up,6–9
there are only isolated reports of an association
between elevated pre-operative cTnI and the risk of
cardiac events or death.10 Most studies of outcomeing author. Simon C. Gibson, MBChB, Department of
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0637+ 05 $35.00/0 q 2005 Published by Elsevier Ltd.either specifically exclude such patients6 or do not
include pre-operative cTnI in their protocol.7,8 The aim
of this study was to ascertain the benefit of routine pre-
operative cTnI measurement in lower extremity
amputation patients with no clinical evidence of
unstable cardiac disease.Materials and MethodsPatients
All patients scheduled for major lower extremity
amputation were prospectively identified in a single
centre between April 2004 and April 2005. Clinical
variables and medications prescribed were recorded,
and the Eagle score (an objective scoring system of
cardiac risk) calculated for each patient.11 Surgery was
considered urgent if it was conducted on the same
admission as emergency referral and elective if
patients were admitted from home for the procedure.
Patients were excluded if there was clinical evidence of
unstable coronary artery disease (cardiac chest pain or
ischaemic ECG changes) at the time of pre-operativeEur J Vasc Endovasc Surg 31, 637–641 (2006)
doi:10.1016/j.ejvs.2005.11.020, available online at http://www.sciencedirect.com on
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emergency (!24 h) or if informed consent could not
be obtained. Local research ethics committee approval
was obtained for this study.Sample collection and analysis
Pre-operative venous blood samples were collected on
the evening prior to surgery in sterile lithium heparin
tubes. Serum cTnI was measured using the ADVIA
Centaurw immunoassay (Bayer Diagnostics), which
has a sensitivity and assay range of 0.1–50 ng/ml.
Results of the cTnI assay, performed exclusively as
part of this study and not requested by clinicians, were
not circulated to treating clinicians. Routine pre-
operative investigations were conducted at the discre-
tion of anaesthetic and surgical staff.Study end points
The study end points were non-fatal MI, and cardiac
death. The definition of MI was that of The Joint
European Society of Cardiology/American College of
Cardiology Committee12 defined as ‘a typical rise and
gradual fall of cTnIwith at least one of the following: (a)
ischaemic symptoms; (b) developmentofpathologicalQ
waves on the ECG; (c) ECG changes indicative of
ischaemia (ST segment elevation or depression); or (d)
coronary artery intervention (e.g. coronary angio-
plasty)’. Cardiac death was determined by a review of
all post-operative data by two cardiologists who were
blinded to pre-operative cTnI levels. Patients were
followed up for 6 weeks after surgery.Post-operative detection and interpretation of cardiac events
Post-operative screening for cardiac events consisted
of daily clinical assessment, serial electrocardiograms
(ECGs) and cTnI measurement (post-operative days 2,
5 and 42). The results of these tests were circulated to
the responsible clinicians. Other investigations were
conducted as clinically indicated. ECG analysis was
performed by two cardiologists blinded to all other
data and patient details, in a batch at the end of the
study period. A separate independent clinician
reviewed 10% of all ECGs, clinical notes and data
analysis to ensure quality control.Statistical analysis
Statistical analysis was conducted using SPSSw stat-
istical software package (SPSS, Chicago, Illinois, USA).Eur J Vasc Endovasc Surg Vol 31, June 2006Univariate analyses between groups were conducted
using a two tailed Fisher’s exact test. Continuous
variables were compared using a two-tailed T-test. A
probability value of less than 0.05 was considered
statistically significant.ResultsPopulation
During the 1-year study, a total of 51 patients
underwent major lower extremity amputation. The
indication for operation in all cases was critical lower
limb ischaemia. In total, there were two amputation
stump infections and one traumatic haematoma. One
patient suffered a chest infection and one a transient
ischaemic attack post-operatively.
Seven patients were excluded (refusal to give
consent—two, inability to give informed consent—
two, emergency surgery—one, unstable cardiac
disease-, and missing pre-operative cTnI sample—
one). One of the excluded patients died from sepsis.
Forty-four patients (28 male, 16 female) with a
median age of 71 (range 41–91) years were included in
this study (Table 1). Thirty-two patients underwent a
below knee amputation and 12 an above knee
amputation, all as primary procedures. Co-morbidity
was common: ischaemic heart disease (15); medically
treated diabetes mellitus (19); chronic obstructive
airways disease (nine); cerebrovascular disease (10);
renal impairment (pre-operative creatinine O
130 mmol/l) (12); hyperlipidaemia (24); hypertension
(33). Twenty-four patients were prescribed statins and
nine were prescribed beta-blockers peri-operatively.
The median Eagle score was 2 (range 0–4). Twelve
procedures were urgent and 32 were elective.Post-operative events
There were 10 post-operative cardiac events: five non-
fatal MIs and five cardiac deaths. Three of the non-fatal
MIs were symptomatic and occurred within 48 h of the
procedure. Two were clinically silent and were
diagnosed by screening (days 2 and 5 post-opera-
tively). Of the five cardiac deaths, one followed an
intra-operative cardiac arrest, the other four being
secondary to myocardial infarction. Two of the fatal
MIs were diagnosed clinically and the patients died
within 2 weeks of the procedure. Two were detected
by screening on day 5, and the patients died following
progression of heart failure in weeks 4 and 5,
respectively.
Table 1. Post-operative cardiac outcome by risk factors
Risk factor n Cardiac
event, n
(%)
No cardiac
event, n
(%)
p*
Sex
Male 28 6 (21%) 22 (79%) 1.000
Female 16 4 (25%) 12 (75%)
Ischaemic heart disease
Yes 15 3 (20%) 12 (80%) 1.000
No 29 7 (24%) 22 (76%)
Diabetes mellitus
Yes 19 5 (26%) 14 (74%) 0.723
No 25 5 (20%) 20 (80%)
COPD
Yes 9 2 (22%) 7 (78%) 1.000
No 35 8 (23%) 27 (77%)
Cerebrovascular disease
Yes 10 2 (20%) 8 (80%) 1.000
No 34 8 (24%) 26 (76%)
Renal impairment
Yes 12 4 (33%) 8 (67%) 0.422
No 32 6 (19%) 26 (81%)
Beta-blocker
Yes 9 1 (11%) 8 (89%) 0.659
No 35 9 (26%) 26 (74%)
Statin
Yes 24 3 (12%) 21 (88%) 0.147
No 20 7 (35%) 13 (65%)
Urgent procedure
Yes 12 4 (33%) 8 (67%) 0.422
No 32 6 (19%) 26 (81%)
EagleO1
Yes 24 7 (29%) 17 (71%) 0.306
No 20 3 (15%) 17 (85%)
Amputation level
BKA 32 6 (19%) 26 (81%) 0.422
AKA 12 4 (33%) 8 (67%)
Elevated cTnI
Yes 3 3 (100%) 0 (0%) 0.009
No 41 7 (17%) 34 (83%)
Total 44 10 34
cTnI, cardiac troponin I.
* Fisher’s exact test.
Table 2. Co-morbidity and outcome in patients with a raised pre-
operative troponin
Patient
1 2 3
Pre-op troponin
(ng/ml)
0.8 0.3 14.8
Pre-op creatinine
(mmol/l)
126 172 50
Ischaemic heart disease Yes Yes No
Diabetes mellitus Yes Yes No
COPD No Yes No
Cerebrovascular
disease
Yes No Yes
Beta-blocker No Yes No
Statin No No No
Urgent procedure Yes Yes Yes
Eagle score 3 4 0
Outcome Cardiac
death
Cardiac
death
Non-fatal
MI
Troponin Measurement Prior to Lower Extremity Amputation 639The median age of those patients having an event
was 76.5 (41–91) compared with 71 (54–86) in those
who were event free (pZ0.503). Post-operative cardiac
events were more common in patients who had renal
impairment, underwent an urgent procedure or who
had an Eagle score of greater than 1. Events were less
likely in patients prescribed statins or beta-blockers.
There was no difference in post-operative cardiac
event rates in patients with a history of ischaemic heart
disease (Table 1).Raised pre-operative troponin
Pre-operative cTnI was raised in three patients (0.8,
14.8, 0.3 ng/ml), all of whom underwent an urgent
procedure (Table 2). Whilst none were prescribed
statins pre-operatively, there were no other consistent
clinical variables. All three patients had post-operativecardiac events with two deaths and one non-fatal MI.
There was no correlation between cTnI level and
severity of event. Patient 1 (pre-operative
cTnIZ0.8 ng/ml) suffered a fatal MI, dying on day
10 post-operatively. Patient 2 (pre-operative
cTnIZ14.8 ng/ml) suffered an MI on day 2 post-
operatively, diagnosed using clinical and ECG criteria.
This patient was discharged home 4 weeks post-
operatively. Patient 3 (pre-operative cTnIZ0.3 ng/ml)
suffered a fatal intra-operative cardiac arrest.Discussion
In this study of patients undergoing major lower
extremity amputation for critical limb ischaemia,
pre-operative cTnI was elevated in 7% of cases and
was associated with a very poor outcome. Whilst
the absolute number of patients recruited was small,
the rigid entry criteria ensured a homogenous,
stable population with consistent surgical and
anaesthetic techniques, without selection bias, and
whose follow up was complete. The study also
employed objective end-points that were clinically
relevant.
Previous studies of patients undergoing amputa-
tion have found high associated co-morbidity and a
high cardiac complication rate.1 In this study of 44
patients, there were nine post-operative MIs, four of
which were silent and only detected by the post-
operative screening protocol. Five patients died of
cardiac causes within 6 weeks of the procedure.
These patients represent a particularly high-risk
group. Knowledge of the pre-operative cTnI might
influence peri-operative support and anaesthetic
techniques.Eur J Vasc Endovasc Surg Vol 31, June 2006
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blockers and statins was disappointingly low given the
published evidence concerning their role in the
prevention of peri-operative cardiac events.13,14 How-
ever, this lower than expected prescription rate is
consistent with other published evidence such as a
recent survey of Canadian anaesthetists.15 Whilst the
numbers in the present study were small, it is
interesting to note that the cardiac event rate was
more than halved in patients prescribed statins or beta-
blockers. Thismay relate to the effect of the drugs,more
aggressive investigation in this group, or may reflect
more stable coronary artery disease in these patients.
Themost important clinical risk factors in determin-
ing the occurrence of post-operative cardiac events
were an urgent procedure and the presence of renal
impairment. Patients with an Eagle score of greater
than 1 were also more likely to suffer an event.
Although none of these reached statistical significance
this probably reflects the small number in each group.
Interestingly, there was no correlation between a
history of ischaemic heart disease and outcome
despite our use of the definition established by Lee
et al.16 This finding may be explained by the high
frequency of occult coronary artery disease in patients
with peripheral vascular disease.3 The simplistic
allocation of cardiac disease into symptomatic and
asymptomatic may not be valid in this cohort.
Myocardial infarction after surgery is more often
silent than symptomatic.17 In this study, one-half of
post-operative MIs were clinically asymptomatic.
Post-operative MI is associated with a poor prognosis
and patients with an asymptomatic rise in post-
operative troponin have been shown to have a worse
outcome at 1 year.7 Therefore, routine post-operative
screening for cardiac events may be beneficial to
identify these high-risk patients, allowing appropriate
cardiac assessment.
Pre-operative cTnI was raised in three patients in
whom it was a universally poor prognostic marker
(two cardiac deaths, one non-fatal MI). Interestingly,
there was no correlation between the level of cTnI rise
and severity of outcome. Few studies have reported
the role of pre-operative cTnI measurement, and those
that have done so confirmed these findings. Hobbs et
al.10 studied peri-operative cTnI in patients with
critical limb ischaemia and described two patients
who had an elevated pre-operative level: one sus-
tained a fatal cardio-pulmonary arrest on table and the
other a markedly raised post-operative troponin and
acute congestive heart failure. The only common
factors among the three patients with a raised pre-
operative cTnI in this study were that they underwent
an urgent procedure, and were not prescribed statins.Eur J Vasc Endovasc Surg Vol 31, June 2006In summary, this study confirms that routine pre-
operative cTnI testing could be used to identify
patients in whom a poor outcome is inevitable. For
these patients it may be preferable to defer surgery
allowing cardiac investigation and optimisation.13 In
some cases, surgery cannot be delayed since the tissue
ischaemia and necrosis is the cause of the cardiac
stress. In this event, the presence of a senior
anaesthetist and surgeon as well as high dependency
care, cardiac optimisation and haemodynamic moni-
toring post operatively may reduce risk.References
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